GLMD
NASDAQ · Biotechnology
Galmed Pharmaceuticals Ltd
$3.63
+0.13 (+3.57%)
EPS Surprise History
Earnings Summary
Beats (Last 2)
1/2
Avg Surprise
+68.0%
Consecutive Beats
1 quarter
Latest EPS
$2.86
History
2 quarters
Earnings History
| Date | Quarter | EPS Est | EPS Actual | Surprise | Surprise % | Result |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | Q3 FY2026 | $-3.18 | $2.86 | +$6.04 | +189.9% | Beat |
| Aug 26, 2026 | Q3 FY2026 | $-3.18 | — | — | — | — |
| Jul 3, 2026 | Q3 FY2026 | $-0.39 | — | — | — | — |
| Jun 17, 2026 | Q2 FY2026 | $-0.39 | — | — | — | — |
| Jun 1, 2026 | Q2 FY2026 | $-0.39 | — | — | — | — |
| May 20, 2026 | Q2 FY2026 | $-0.39 | — | — | — | — |
| Mar 31, 2026 | Q1 FY2026 | $-0.52 | $-0.80 | -$0.28 | -53.8% | Miss |